MediciNova Inc. (Nasdaq:MNOV) announced the appointment of Mr. Tatsuo Izumi to its Board of Directors.
MediciNova, Inc., a biopharmaceutical company, engages in the acquisition and development of small-molecule therapeutics for the treatment of serious diseases for the United States market.
Read the full article and the disclaimer at:http://bestotc.com/18618/stock-alerts/mnov-pedh-west-clno-featured-stocks-by-bestotccom/
(MNOV, PEDH, WEST, CLNO) Featured Stocks by BestOtc.com
October 7th, 2011 at 09:19 am